期刊
PEDIATRIC REPORTS
卷 14, 期 3, 页码 320-332出版社
MDPI
DOI: 10.3390/pediatric14030039
关键词
extracorporeal membrane oxygenation; ECMO; extracorporeal life support; anticoagulation; bleeding; thrombosis; children
类别
Extracorporeal Membrane Oxygenation (ECMO) is a commonly used treatment for critically ill children, but it carries the risk of bleeding and thrombosis. The management and diagnostic monitoring of anticoagulation in children receiving ECMO vary widely, indicating the need for further research and exploration.
Extracorporeal Membrane Oxygenation (ECMO) is often used in critically ill children with severe cardiopulmonary failure. Worldwide, about 3600 children are supported by ECMO each year, with an increase of 10% in cases per year. Although anticoagulation is necessary to prevent circuit thrombosis during ECMO support, bleeding and thrombosis are associated with significantly increased mortality risk. In addition, maintaining balanced hemostasis is a challenging task during ECMO support. While heparin is a standard anticoagulation therapy in ECMO, recently, newer anticoagulant agents are also in use. Currently, there is a wide variation in anticoagulation management and diagnostic monitoring in children receiving ECMO. This review intends to describe the pathophysiology of coagulation during ECMO support, review of literature on current and newer anticoagulant agents, and outline various diagnostic tests used for anticoagulation monitoring. We will also discuss knowledge gaps and future areas of research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据